Lots of holders mentioning BP as potential acquirer of NEU (and potentially even ACAD)...
Given we now know:
2591 is safe
2591 is tolerable
2591 works on humans as it did in the mouse models
2591 is easier to produce than trof
2591 method of action is superior to trof
Lackluster results of the TBI trials appear to be related to dosing issues primarily
My question is, should we be adding the US Army back into the mix of potential acquirers...?
Merck to acquire Prometheus in a US$ 10.8 b deal, page-61
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.71 |
Change
-0.590(3.41%) |
Mkt cap ! $2.135B | |||
| Open | High | Low | Value | Volume |
| $17.50 | $17.55 | $16.57 | $10.01M | 594.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 598 | $16.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.87 | 1676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |